Ditazole
From Wikipedia, the free encyclopedia
|
Ditazole
|
|
| Systematic (IUPAC) name | |
| 2,2'-(4,5-diphenyloxazol-2-ylazanediyl)diethanol | |
| Identifiers | |
| CAS number | |
| ATC code | B01 |
| PubChem | |
| Chemical data | |
| Formula | C19H20N2O3 |
| Mol. mass | 324.374 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Ditazole is a platelet aggregation inhibitor.It is marketed in Spain and Portugal under the trade name Ageroplas.[1]
[edit] References
- ^ Martindale's Complete Drug Reference,http://www.medicinescomplete.com/mc/martindale/current/2639-d.htm
- The Merck Index, 12th Edition. 3432
|
||||||||||||||||||||||||||

